Logo

Affy and IBM to Collaborate on Integrating Genomic, Patient Data

Mar 30, 2004

NEW YORK, GenomeWeb News (March 30) - IBM and Affymetrix will collaborate to integrate genomic research data and patient information, the companies said today.

 

Affymetrix and IBM plan to combine open standards technologies, including Affymetrix's GeneChip technology and IBM's services in regulatory compliance, business integration, and systems integration, to create a system that will allow researchers to cross-reference genomic data with patient data.

 

In their collaboration, IBM and Affymetrix plan to work with research organizations and institutes, pharmaceutical companies, and other organizations.

 

The H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida will collaborate with the two companies to design clinical trials that take into account genetic research.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.